PR93046

NANJING, China, Nov. 15, 2021 /PRNewswire=KYODO JBN/ --

On November 15, 2021, Nanjing Vazyme Biotech Co., Ltd. (Vazyme) went public on

the STAR MARKET of the Shanghai Stock Exchange under the stock code 688105.

Founded in Nanjing in 2012, Vazyme develops technologies and products related

to functional proteins including enzymes, antigens and antibodies as well as

organic polymer materials. Relying on its proprietary critical generic

technology platform, the company has successively entered business areas

including biological research, in vitro diagnosis and biomedicine. Vazyme is

one of the few innovative R&D companies with both independent and controllable

upstream technology development and final product manufacturing capabilities in

China. The company owns more than 200 kinds of genetic engineering recombinases

and 1,000 kinds of high-performance antigens and monoclonal antibodies. In

addition, Vazyme has over 500 final products that have wide applications in

scientific research, high-throughput sequencing, in vitro diagnosis,

pharmaceutical and vaccine development as well as animal quarantine, among

other fields.

Backed by many years of experience in the molecular biological reagent segment,

Vazyme has strong R&D and product iteration capabilities, a perfected technical

system and a well-established marketing network. Looking ahead, the

publicly-listed company plans to accelerate its roadmap for an expanded

presence in global markets, with the expectation of contributing to the ongoing

development of the world's biotechnology sector.

At the ceremony celebrating the firm's success at listing on the Shanghai Stock

Exchange, Vazyme chairman and founder Cao Lin said, "Today's listing is of

great significance to Vazyme. We have worked on obtaining this listing for

nearly 10 years, in this period we made our full efforts and experienced all

kinds of hardships. Vazyme will strictly comply with each and every one of the

requirements and rules for listed companies, constantly enhance our management,

communicate regularly with investors and maintain the transparency of our

company, as part of our mission to give back to society and the shareholders by

way of sustained growth and better performance."

SOURCE: Vazyme

Image Attachments Links:

   Link: http://asianetnews.net/view-attachment?attach-id=407513

   Caption: Vazyme goes public on Shanghai Stock Exchange today